Assignee
SHIRE VIROPHARMA INC
US·10 granted patents·7 pending applications·39 citations·filing 2014–2020
Top patents by PatentIndex Score
17 records- 0194US10080788B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Sep 25, 2018·4 cites·30 claims
- 0294US9616111B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2015·Granted Apr 11, 2017·12 cites·18 claims
- 0392US10765692B2Maribavir isomers, compositions, methods of making and methods of usingSHIRE VIROPHARMA INC·Filed 2019·Granted Sep 8, 2020·4 cites·9 claims
- 0491US10485813B2Maribavir isomers, compositions, methods of making and methods of usingSHIRE VIROPHARMA INC·Filed 2016·Granted Nov 26, 2019·9 cites·9 claims
- 0591US10201595B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Feb 12, 2019·2 cites·30 claims
- 0691US10130690B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Nov 20, 2018·2 cites·29 claims
- 0791US10105423B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Oct 23, 2018·2 cites·29 claims
- 0874US2019160158A1C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2018·Application pending·0 cites
- 0972US9895428B2Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2014·Granted Feb 20, 2018·2 cites·27 claims
- 1069US10272142B2Compositions and methods useful for the treatment of neuromyelitis optica spectrum disordersSHIRE VIROPHARMA INC·Filed 2014·Granted Apr 30, 2019·2 cites·17 claims
- 1169US2017224788A1C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Application pending·0 cites
- 1260US2016175338A1Maribavir isomers, compositions, methods of making and methods of usingSHIRE VIROPHARMA INC·Filed 2016·Application pending·0 cites
- 1359US2020360495A1Methods of treating antibody-mediated rejection in organ transplant patients with c1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2020·Application pending·0 cites
- 1457US10583146B2Pharmaceutical compositions for glucocorticoid replacement therapySHIRE VIROPHARMA INC·Filed 2014·Granted Mar 10, 2020·0 cites·23 claims
- 1555US2016304549A1Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-l-ribofuranosyl)-1h-benzimidazoleSHIRE VIROPHARMA INC·Filed 2016·Application pending·0 cites
- 1650US2018104319A1Methods of treating antibody-mediated rejection in organ transplant patients with c1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2017·Application pending·0 cites
- 1746US2016106786A1Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and useSHIRE VIROPHARMA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHIRE VIROPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →